眼前房:钆对比剂自然排泄途径的入口?
本研究回顾性分析200只健康眼(对侧视网膜母细胞瘤患儿),在全身麻醉下用眼眶线圈行MRI,于注射大环内酯类钆对比剂后约12分钟检测眼前房信号强度比变化。结果显示注射后眼前房信号强度显著增高(中位∆SIR +0.08,p<0.0001),且钆增强与患儿年龄呈强负相关(p<0.0001)。作者认为钆可快速渗漏至婴幼儿眼前房,未来需评估其持续时间、潜在诊断应用及安全性。
要点
- 注射钆对比剂后约12分钟,健康眼眼前房信号强度即显著增高(中位∆SIR +0.08,p<0.0001)。
- 眼前房钆增强与患儿年龄呈强负相关(p<0.0001),可能反映血-房水屏障或Schlemm管成熟过程。
- 儿童增强MRI中眼前房信号增高可能是钆对比剂渗漏的表现,需结合年龄解读。
关键影像表现/征象
- 健康眼眼前房在注射钆对比剂后约12分钟出现信号强度增高,中位∆SIR(四分位距)= +0.08(0.05-0.12),p<0.0001。
- 眼前房钆增强与患儿年龄在多变量分析(校正注射后时间)中呈强负相关(p<0.0001)。
诊断标准与关键数值
- 以眼前房与晶状体的信号强度比(SIR)在增强前后的差值(∆SIR)作为评价指标,注射后中位∆SIR为+0.08(0.05-0.12),p<0.0001。
临床应用与阅片要点
- 儿童增强MRI中可观察到眼前房信号增高,提示钆对比剂可快速渗漏至眼前房,判读时需注意年龄因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Previous studies provided evidence that gadolinium can be found in the aqueous chamber (AC) of the eye several hours post injection (p.i.) of gadolinium-based contrast agents (GBCAs). This study aimed to investigate whether gadolinium can be detected promptly after injection of a macrocyclic GBCA on contrast-enhanced T1-weighted MRI in the AC of children.
METHODS: This retrospective study encompassed MRI of 200 healthy eyes of children suffering from retinoblastoma of the contralateral eye. MRI was performed with an orbital coil with the children in a state of general anesthesia. Differences of signal intensity ratios (∆SIRs) of the AC to the lens were determined between pre and post contrast-enhanced T1-weighted images (Dotarem®, Guerbet, 0.1 ml/kg body weight, mean (standard deviation) p.i. time = 12:24 (± 2:31) min).
RESULTS: A highly significant signal intensity increase was found in the AC of healthy eyes 12 min after GBCA injection (median ∆SIR (interquartile range) = + 0.08 (0.05-0.12), p < 0.0001). In addition, gadolinium enhancement showed a strong negative correlation with children's age in multivariate analysis with adjustment for p.i. time (p < 0.0001).
CONCLUSIONS: GBCA leakage into the AC of healthy infantile eyes was found promptly after injection. The negative correlation between patient age and GBCA enhancement might be explained by a maturation process of the blood-aqueous barrier or Schlemm's canal. Future studies should assess the duration and potential diagnostic applications as well as possible safety concerns of gadolinium presence in the AC.
KEY POINTS: • Leakage of gadolinium-based contrast agent into the aqueous chamber of infantile eyes was found promptly after intravenous injection (p < 0.0001). • Gadolinium enhancement of the anterior eye chamber was negatively correlated with the children's age (p < 0.0001).
引用
- Deike-Hofmann K, von Lampe P, Schlemmer HP, et al. The anterior eye chamber: entry of the natural excretion pathway of gadolinium contrast agents? Eur Radiol. 2020. PMID: 32179994. doi:10.1007/s00330-020-06762-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。